Home
News
Latest News
People Moves
Business Briefs
Newsletters
Features
Features
Reprints
Surveys
Editorial Calendar
Web Exclusives
Issue Archive
Events
MM&M Awards 2012
txt4pharma
MM&M Virtual Summit
Webcasts
Leadership Exchanges
Whitepapers
Directories
Creative Portfolio
Mobile Guide
Interactive Guide
Pharmaceutical Marketers Directory
MM&M Service Directory
Agency Gallery
Direct Marketing Showcase
Medical Education Review
Sales Force Listings
Jobs
About Us
Subscriber Services
Contact Us
Media Information
Editorial Advisory Board
Drug Info
New Drug Dossier
Drug Database
Subscribe
Order Now
Subscriber Services
Newsletters
RSS
|
Login
|
Register
Features Articles
Mobile: Get Smart
James Chase
February 06, 2012
It's amazing what you can do with mobile these days. So isn't it time you did something amazing with mobile? James Chase charts the data points and the pain points
Overview: A Movable Feast
Matthew Arnold
February 03, 2012
Marketing now means digital, digital means mobile and search is no longer the starting point for online promotion. Matthew Arnold charts the trends
Patient Education: Vying for Attention
Marc Iskowitz
February 01, 2012
Marc Iskowitz on how Shire's disease-awareness campaign engaged untreated Gen Y-ers, and why it's time for more patient-education efforts like it. Plus: See patient advocates discuss the ADHD market
MM&M Therapeutic Focus: Cardiovascular
Noah Pines February 01, 2012
New cardiovascular treatments are gaining FDA approval as massive brands lose patent protection. Noah Pines on the potential of these new entrants to replace that lost revenue
Medical Advertising Hall of Fame: Lasting Legends
February 01, 2012
The Medical Advertising Hall of Fame's three new members have had exceptional lives and careers. We look back at their achievements
Managed Care: Preferential Treatment
Elizabeth Jeffords February 01, 2012
Pharma firms are partnering with managed care companies to find drug evidence and improve outcomes. Can this strategy provide the proof payers demand before giving products preferential treatment?
MM&M Awards: The Hunt for Red October
James Chase
February 01, 2012
The MM&M Awards 2012 program is open for business.
Headliner: Fred Wilkinson, Watson Pharmaceuticals
Tanya Lewis February 01, 2012
Fred Wilkinson's "second tour of duty" at Watson includes global expansion, R&D investing and launching branded and generic products
All-Star Company of the Year: Boehringer Ingelheim
Matthew Arnold
January 01, 2012
Company of the Year: Boehringer Ingelheim. From left: President/CEO Greg Behar; David Pass, VP, US pipeline marketing; and Kathleen Dowd, VP, respiratory marketing
All-Star Agency of the Year: ICC Lowe
Marc Iskowitz
January 01, 2012
Agency/Network of the Year: ICC Lowe. From left: Steve Viviano, CEO; Chet Moss, chief creative officer; Paul O'Neil, president, ICC Lowe
« Previous
Next »
Video Exclusive
Web Exclusives
Five industry experts advise specialty pharma company on digital strategy
April 20, 2012
Specialty pharma company POZEN assembled a crack team of experts to help shape its digital strategy. Not only did POZEN share with us the text from their contributions, but you can watch exclusive video clips of their valuable perspectives right here.
MM&M Awards 2011 HIghlights
The Best MM&M Awards Ever!
MAHF Ceremony 2012
Photos from the Medical Advertising Hall of Fame Awards ceremony
Most Popular
Most Emailed
Most Recent
Goodbye Plavix, hello competition
Sales forces shrank in 2011, but not everywhere
Pharmas are from Mars, Payers are from Venus
No-see docs are know-nothings when it comes to new drug info, study suggests
Study: Young Latinas are key decision makers, prefer English
How CDC's hep.-C testing advice benefits drugmakers now
Indian conglomerate buys Manhattan Research parent for $635m
PhRMA's Washington wish list
E-prescriptions boost adherence data
Roundtable outlines path for publisher, pharma credibility
Study: Young Latinas are key decision makers, prefer English
No-see docs are know-nothings when it comes to new drug info, study suggests
Pharmas are from Mars, Payers are from Venus
Indian conglomerate buys Manhattan Research parent for $635m
E-prescriptions boost adherence data
Goodbye Plavix, hello competition
Sales forces shrank in 2011, but not everywhere
How CDC's hep.-C testing advice benefits drugmakers now
PhRMA's Washington wish list
Roundtable outlines path for publisher, pharma credibility
Did FDA's Vytorin warning negatively impact health outcomes?
Roundtable outlines path for publisher, pharma credibility
No-see docs are know-nothings when it comes to new drug info, study suggests
E-prescriptions boost adherence data
How CDC's hep.-C testing advice benefits drugmakers now
PhRMA's Washington wish list
Study: Young Latinas are key decision makers, prefer English
Pharmas are from Mars, Payers are from Venus
Goodbye Plavix, hello competition
Indian conglomerate buys Manhattan Research parent for $635m
Popular Topics
Acquisition
Adherence
App
Celebrity
Clinical Trial
Co-Marketing
Conflict Of Interest
Diabetes
Diagnostics
Digital
Direct To Consumer (DTC)
Disease Awareness
Downsize
Education & Awareness
FDA
Government
Guidance
Health Plans
HMOs
Hospitals
Insurers
Law
Marketing Research
Medical Journal
Sales Force